NIAID funds pediatric AIDS clinical trials group. National Institute of Allergy and Infectious Diseases. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply. NLM AIDSLINE Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


NIAID funds pediatric AIDS clinical trials group. National Institute of Allergy and Infectious Diseases. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.

NIAID AIDS Agenda. 1997 Mar;:12. Unique Identifier : AIDSLINE AIDS/97702460
Doepel L


Abstract: The National Institute of Allergy and Infectious Diseases (NIAID) has awarded 23 4-year grant programs to the Pediatric AIDS Clinical Trials Group, a national network that coordinates research projects. The money will support 21 trials, a data management center, and a new Coordinating and Operating Center. The restructured group's ability to conduct trials that address questions of high public health and scientific priority will be enhanced. As of February 1997, the group has initiated 60 trials, is currently recruiting patients for 27 studies, and has enrolled 10,867 participants.
Keywords: Acquired Immunodeficiency Syndrome/EPIDEMIOLOGY Adolescence Child Child, Preschool Clinical Trials/*ECONOMICS *Disease Transmission, Vertical Female *Financing, Government HIV Infections/PREVENTION & CONTROL/*THERAPY/*TRANSMISSION Human Infant Infant, Newborn Pregnancy United States/EPIDEMIOLOGY NEWSLETTER ARTICLEKWDacquiredimmunodeficiencysyndrome/epidemiologyadolescencechildchild,preschoolclinicaltrials/KWDeconomicsKWDdiseasetransmission,verticalfemaleKWDfinancing,governmenthivinfections/prevention&control/KWDtherapy/KWDtransmissionhumaninfantinfant,newbornpregnancyunitedstates/epidemiologynewsletterarticle
970830
M9781263

Copyright © 1997 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .